BCL2 and breast carcinoma: Quercetagetin induced apoptosis in a small proportion of our cells (approximately 20%), evident in morphological results and supported by the detection of active caspase-3 and decreased BCL2 expression in both human (as previously reported [8]) and murine (JC) breast cancer cells.